Brainstorm Cell Therapeutics Inc.

$BCLI continues to fall. Down just over 50% on the day at the time of posting. Advisors to the U.S. Food and Drug Administration on Wednesday voted down the company’s investigational treatment for amyotrophic lateral sclerosis (ALS)

Share This Article

 

About the Author

Brainstorm Cell Therapeutics Inc.

Joey Ramson